S-1/A: Hinge Health Files for IPO, Aiming to Revolutionize Musculoskeletal Care

Hinge Health, a leading technology platform for musculoskeletal (MSK) care, has filed for an IPO to further its mission of transforming outcomes, experience, and costs through technology.

Summary

• Hinge Health, a technology platform focused on MSK care, has filed for an IPO.
• The company aims to transform healthcare by scaling and automating care delivery, particularly in the MSK space.
• Hinge Health's platform uses AI-powered motion tracking and wearable devices, supported by a care team, to provide personalized MSK care.
• The company estimates its platform reduces human care team hours by approximately 95% compared to traditional physical therapy.
• Hinge Health's revenue for 2024 was $390.4 million, a 33% increase year-over-year, with a gross margin of 77%.
• As of December 31, 2024, Hinge Health had over 2,250 clients and approximately 20 million contracted lives.
• The company is expanding into fully-insured and Medicare Advantage markets, as well as international markets.
• Hinge Health incurred net losses of $11.9 million in 2024 and $108.1 million in 2023.
• The company's preliminary operating results for the three months ended March 31, 2025, show expected revenue between $ million and $ million.
• The company expects income from operations for the three months ended March 31, 2025 to be between $ million and $ million.
• The company expects non-GAAP income from operations for the three months ended March 31, 2025 to be between $ million and $ million.
• The company expects LTM calculated billings as of the three months ended March 31, 2025 to be between $ million and $ million.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth, improving gross margins, and expansion into new markets. However, the company's history of net losses and the risks associated with its business model temper the overall sentiment.

Positives

• Significant revenue growth and high gross margins.
• Large client base and contracted lives.
• Expansion into new markets.
• Technology-driven platform with high automation.
• Positive member outcomes and client ROI.
• Strong partner network.
• The company expects income from operations for the three months ended March 31, 2025 to be between $ million and $ million.
• The company expects non-GAAP income from operations for the three months ended March 31, 2025 to be between $ million and $ million.
• The company expects LTM calculated billings as of the three months ended March 31, 2025 to be between $ million and $ million.

Negatives

• History of net losses and accumulated deficit.
• Reliance on a limited number of health plans and partners.
• The company incurred net losses of $11.9 million in 2024 and $108.1 million in 2023.

Risks

• Inability to achieve or maintain profitability.
• Failure to manage growth effectively.
• Inability to attract new clients or retain existing ones.
• Increasing reliance on AI and machine learning technologies may expose the company to significant risks.
• Potential intellectual property infringement claims.
• Changes in healthcare regulations.
• The price of the Class A common stock may be volatile or may decline regardless of the company's operating performance.
• The dual class structure of the common stock will have the effect of concentrating voting control with the holders of the Class B common stock, including Daniel Perez and Gabriel Mecklenburg (our Founders), and the holders of our Series E preferred stock, who will collectively hold in the aggregate % of the voting power of our capital stock following the completion of this offering.
• Following this offering, 50% of the shares of our Series E preferred stock originally issued to investors will remain outstanding, and such shares will initially be held by one holder of our Series E preferred stock, Tiger Global, and the holders of our Series E preferred stock will retain rights that could impact the value of our Class A common stock and impact our business and operations.

Future Outlook

The company expects continued growth by expanding its client base, increasing adoption across existing clients, launching new programs, and expanding into new markets.

Industry Context

The announcement highlights the growing trend of using technology and AI to improve healthcare delivery, particularly in the MSK market, which is facing challenges related to access, cost, and effectiveness of traditional treatments.

Comparison to Industry Standards

• The document mentions competitors such as Kaia Health Software, Inc., Omada Health, Inc., Sword Health Technologies, Inc., and Vori Health, Inc.
• Hinge Health differentiates itself through its scale, AI technology, data advantage, and outcomes for members and ROI for clients.
• The company's 2023 Employer Claims Study estimated a 2.4x ROI for clients, based on the estimated $2,387 average cost savings per member over a 12-month period divided by the cost of our chronic program.
• The 2020 Longitudinal Study that evaluated the efficacy of our platform in a large population of participants with chronic knee and back pain where participants reported a 68% average improvement in reported pain and a 58% reduction in reported depression and anxiety after 12 weeks.

Related Party Transactions

• The document mentions an investors rights agreement with certain stockholders.
• The document mentions a right of first refusal agreement with certain stockholders.
• The document mentions loans to certain officers and directors.
• The document mentions legal services provided by Perkins Coie LLP, where a sibling of the CEO is a partner.
• The document mentions a preferred stock repurchase agreement with Coatue.
• The document mentions a participation letter with Coatue.

Stakeholder Impact

• Shareholders: Potential for increased value through company growth and market expansion.
• Employees: Continued employment and potential for equity appreciation.
• Customers: Access to innovative and effective MSK care solutions.
• Suppliers: Potential for increased business through company growth.
• Creditors: Increased financial stability through IPO proceeds.

Next Steps

• Expand client base in core markets.
• Expand into new markets.
• Increase adoption across existing client base.
• Launch new programs and capabilities driven by investment in our platform.

Key Dates

Keywords

musculoskeletal, MSK, Hinge Health, IPO, digital health, physical therapy, healthcare, AI, artificial intelligence, telehealth